中國的肝素出口(2023年~2032年)
市場調查報告書
商品編碼
1184676

中國的肝素出口(2023年~2032年)

Research Report on China's Heparin Export 2023-2032

出版日期: | 出版商: China Research and Intelligence | 英文 50 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

樣本圖


中國肝素的出口量,2022年1月~11月達到與前一年同期比增加18.05%的132.00噸,出口額達到了與前一年同期比增加1.90%的14億4,100萬美元。隨著全球高齡化趨勢的加速,循環系統疾病的流行,居民的健康意識提高,肝素的市場規模也慢慢擴大。

本報告提供中國的肝素出口調查分析,出口情形和外銷處,COVID-19影響,預測收益等資訊。

目錄

第1章 中國的肝素出口的分析(2018年~2022年)

  • 中國的肝素的出口規模
    • 中國的肝素的出口量
    • 中國的肝素的出口額
    • 中國的肝素的出口價格
  • 中國的肝素的主要外銷處
    • 各出口量
    • 各出口額

第2章 中國的肝素鈉出口的分析(2018年~2022年)

  • 中國的肝素鈉的出口規模
    • 中國的肝素鈉的出口量
    • 中國的肝素鈉的出口額
    • 中國的肝素鈉的出口價格
  • 中國的肝素鈉主要外銷處
    • 各出口量
    • 各出口額

第3章 中國的肝素鋰出口的分析(2018年~2022年)

  • 中國的肝素鋰的出口規模
    • 中國的肝素鋰的出口量
    • 中國的肝素鋰的出口額
    • 中國的肝素鋰的出口價格
  • 中國的肝素鋰的主要外銷處
    • 各出口量
    • 各出口額

第4章 中國的肝素與其鹽的出口整體分析(2018年~2022年)

  • 中國的肝素與其鹽的出口規模
    • 中國的肝素與其鹽的整體出口量
    • 中國的肝素與其鹽的整體出口額
    • 中國的肝素與其鹽的出口價格
  • 中國的肝素與其鹽的主要外銷處
    • 各出口量
    • 各出口額

第5章 中國的肝素的主要外銷處的分析(2018年~2022年)

  • 香港,中國
  • 義大利
  • 印度
  • 日本
  • 俄羅斯
  • 其他的外銷處

第6章 中國的肝素出口預測(2023年~2032年)

  • 中國的肝素出口的影響因素
    • 有利的要素
    • 不利的要素
  • 中國的肝素出口的預測(2023年~2032年)
    • 出口量的預測
    • 主要外銷處的預測
    • 肝素的主要出口類型的預測
簡介目錄
Product Code: 2301719

Heparin is a natural and highly sulfated glycosaminoglycan anticoagulant. Heparin API is the raw material for antithrombotic and anticoagulant drugs such as low molecular weight heparin preparations, which are widely used in cardiovascular, cerebrovascular, joint replacement, hemodialysis and other surgeries and treatments. With the accelerating trend of global population aging, the prevalence of cardiovascular diseases and the improvement of residents' health awareness, the market size of heparin is also gradually expanding.

SAMPLE VIEW


China is one of the major heparin exporters in the world, exporting a large amount of heparin every year. According to CRI analysis, in 2021, China exported 125.05 tons of heparin, down 17.72% year-on-year, with an export value of US$1,597 million, up 20.86% year-on-year. From January to November 2022, China exported 132.00 tons of heparin, up 18.05% year-on-year, with an export value of US$1,441 million, up 1.90% year-on-year.

In 2021, China exported heparin to more than sixty countries and regions worldwide. CRI analysis shows that Hong Kong, China, Italy, India, Japan and the Russian Federation are the major export destinations of heparin from China by export volume. Among them, Hong Kong, China is the largest destination for China's heparin exports. In 2021, China exported 40.59 tons of heparin to Hong Kong, China, accounting for 32.46% of the total heparin exports in that year, and the export value was US$455 million, accounting for 28.49% of the total export value.

China is a major global producer and exporter of heparin APIs, and CRI expects the Chinese heparin export market to remain stable in the future.

Topics covered:

  • China's Heparin Export Status and Major Sources in 2018-2022
  • What is the Impact of COVID-19 on China's Heparin Export?
  • Which Companies are the Major Players in China's Heparin Export Market and What are their Competitive Benchmarks?
  • Key Drivers and Market Opportunities in China's Heparin Export
  • What are the Key Drivers, Challenges, and Opportunities for China's Heparin Export during 2023-2032?
  • What is the Expected Revenue of China's Heparin Export during 2023-2032?
  • What are the Strategies Adopted by the Key Players in the Market to Increase Their Market Share in the Industry?
  • What are the Competitive Advantages of the Major Players in China's Heparin Export Market?
  • Which Segment of China's Heparin Export is Expected to Dominate the Market in 2032?
  • What are the Major Adverse Factors Facing China's Heparin Export?

Table of Contents

1. 2018-2022 China Heparin Export Analysis

  • 1.1. Export Scale of Heparin from China
    • 1.1.1. Export Volume of Heparin from China
    • 1.1.2. Export Value of Heparin from China
    • 1.1.3. Export Price of Heparin from China
  • 1.2. China's Main Export Destinations of Heparin
    • 1.2.1. By Export Volume
    • 1.2.2. By Export Value

2. 2018-2022 China Heparin Sodium Export Analysis

  • 2.1. China's Heparin Sodium Export Scale
    • 2.1.1. China's Heparin Sodium Export Volume
    • 2.1.2. China's Heparin Sodium Export Value
    • 2.1.3. China's Export Price of Heparin Sodium
  • 2.2. China's Main Export Destinations of Heparin Sodium
    • 2.2.1. By Export Volume
    • 2.2.2. By Export Value

3. 2018-2022 China Heparin Lithium Export Analysis

  • 3.1. China's Heparin Lithium Export Scale
    • 3.1.1. China's Heparin Lithium Export Volume
    • 3.1.2. China's Heparin Lithium Export Value
    • 3.1.3. Export Price of Heparin Lithium from China
  • 3.2. China's Main Export Destinations of Heparin Lithium
    • 3.2.1. By Export Volume
    • 3.2.2. By Export Value

4. 2018-2022 China Heparin and its Salts Overall Export Analysis

  • 4.1. China's Heparin and its Salts Export Scale
    • 4.1.1. China's Heparin and its Salts Total Export Volume
    • 4.1.2. Total Export Value of Heparin and its Salts in China
    • 4.1.3. Export Price of Heparin and its Salts in China
  • 4.2. China's Main Export Destinations of Heparin and its Salts
    • 4.2.1. By Export Volume
    • 4.2.2. By Export Value

5. 2018-2022 China Heparin Major Export Destinations Analysis

  • 5.1. Hong Kong, China
  • 5.2. Italy
  • 5.3. India
  • 5.4. Japan
  • 5.5. Russian Federation
  • 5.6. Other Export Destinations

6. China's Heparin Export Outlook 2023-2032

  • 6.1 Factors Affecting China's Heparin Exports
    • 6.1.1 Favorable Factors
    • 6.1.2. Unfavorable Factors
  • 6.2. China's Heparin Export Forecast, 2023-2032
    • 6.2.1. Export Volume Forecast
    • 6.2.2. Major Export Destinations Forecast
    • 6.2.3. Major Export Types of Heparin Forecast